<?xml version="1.0" encoding="utf-8" standalone="no"?>
<key-projects>
  <projects>
    <title>Development of OCI's International Investigative Unit</title>
    <description>FDA’s commitment for protecting the public health does not stop at the borders of the United States.  The FDA/Office of Criminal Investigations (OCI) is also committed to continuing our mission to build and foster strong working relationships with foreign law enforcement agencies in countries throughout the world.  OCI’s role and responsibilities for the FDA is to identify and prosecute violators who import counterfeit, misbranded and/or adulterated FDA-regulated products that threaten the health and safety of the American public. The objective of this project is to coordinate with other FDA components to develop an outreach training and presentation curriculum program to continue building international relations.  The training and presentation curriculum program will enhance relations with foreign law enforcement and regulatory counterparts regarding OCI’s role and responsibilities for conducting criminal investigations. </description>
    <description>Information is current as of February 12, 2013</description>
    <dictionary></dictionary>
    <outcome></outcome>
    <accomplishment></accomplishment>
    <table>
      <title></title>
      <overall-status>
        <briefing>ON TRACK</briefing>
        <prior-briefing>ON TRACK</prior-briefing>
      </overall-status>
      <row>
        <type></type>
        <milestone-description>1. Develop an outreach and presentation curriculum for OIP personnel relative to OCI’s roles and responsibilities for international related investigations.</milestone-description>
        <milestone-date>3/30/2013</milestone-date>
        <milestone-status>On Track</milestone-status>
        <milestone-completion-date></milestone-completion-date>
      </row>
      <row>
        <type></type>
        <milestone-description>2. Develop an outreach and training curriculum for foreign law enforcement entities relative to OCI's international investigative role and responsibilities.</milestone-description>
        <milestone-date>6/30/2013</milestone-date>
        <milestone-status>On Track</milestone-status>
        <milestone-completion-date></milestone-completion-date>
      </row>
      <row>
        <type></type>
        <milestone-description>3. Develop an outreach curriculum for industry relative to OCI's international investigative role and responsibilities.</milestone-description>
        <milestone-date>6/30/2013</milestone-date>
        <milestone-status>On Track</milestone-status>
        <milestone-completion-date></milestone-completion-date>
      </row>
      <row>
        <type></type>
        <milestone-description>4. Enhance OCI’s liaison activities with foreign law enforcement entities.</milestone-description>
        <milestone-date>9/30/2013</milestone-date>
        <milestone-status>On Track</milestone-status>
        <milestone-completion-date></milestone-completion-date>
      </row>
      <footnotes>
        <note></note>
      </footnotes>
    </table>
  </projects>
  <related-links>
    <link>
      <url>http://www.fda.gov/AboutFDA/Transparency/track/ucm204013.htm</url>
      <text>FDA-TRACK ORA Dashboard</text>
    </link>
  </related-links>
</key-projects>਍††਍਍਍਍਍਍਍